|
ZFP90 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.51549994565192E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.52040000045828E-07 |
| Normal-vs-Stage2 |
2.942200E-02 |
| Normal-vs-Stage3 |
2.202600E-01 |
| Normal-vs-Stage4 |
5.168600E-01 |
| Stage1-vs-Stage2 |
9.121400E-01 |
| Stage1-vs-Stage3 |
1.718840E-01 |
| Stage1-vs-Stage4 |
1.865630E-01 |
| Stage2-vs-Stage3 |
4.126000E-01 |
| Stage2-vs-Stage4 |
2.855400E-01 |
| Stage3-vs-Stage4 |
7.495000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14139999674023E-08 |
| Normal-vs-AfricanAmerican |
5.396500E-04 |
| Normal-vs-Asian |
1.031380E-01 |
| Caucasian-vs-AfricanAmerican |
2.403000E-01 |
| Caucasian-vs-Asian |
9.355600E-01 |
| AfricanAmerican-vs-Asian |
7.381600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22760000445632E-08 |
| Normal-vs-Female |
9.93580000000494E-05 |
| Male-vs-Female |
8.736400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.126820E-01 |
| Normal-vs-Extreme_Weight |
1.616910E-04 |
| Normal-vs-Obese |
2.15019999999511E-05 |
| Normal-vs-Extreme_Obese |
3.152000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.831600E-02 |
| Normal_Weight-vs-Obese |
5.117600E-03 |
| Normal_Weight-vs-Extreme_Obese |
6.458800E-01 |
| Extreme_Weight-vs-Obese |
1.911380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.251600E-01 |
| Obese-vs-Extreme_Obese |
3.737600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.215600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.06829999688441E-08 |
| Normal-vs-Age(61-80Yrs) |
1.1515000000184E-06 |
| Normal-vs-Age(81-100Yrs) |
9.617000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.837600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.964400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.208810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.686000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.319400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.255900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.69384556065233E-14 |
| Normal-VS-Type2 PRCC |
8.670000E-01 |
| Normal-VS-KIRP CIMP |
7.228000E-01 |
| Normal-VS-Unclassified PRCC |
8.606500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.18689971581898E-10 |
| Type1 PRCC-VS-KIRP CIMP |
1.443650E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.909000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.746600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.396830E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.229500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.410400E-02 |
| Normal-vs-N1 |
1.147570E-01 |
| Normal-vs-N2 |
7.832400E-02 |
| N0-vs-N1 |
8.786600E-01 |
| N0-vs-N2 |
1.420850E-01 |
| N1-vs-N2 |
1.345620E-01 |
|
|
